Immatics NV (IMTX)
9.11
+0.42
(+4.83%)
USD |
NASDAQ |
Aug 25, 13:51
Immatics Net Income (Quarterly) : -72.66M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -72.66M |
| March 31, 2026 | -67.64M |
| December 31, 2025 | -41.55M |
| September 30, 2025 | -59.07M |
| June 30, 2025 | -79.74M |
| March 31, 2025 | -41.95M |
| December 31, 2024 | 47.86M |
| September 30, 2024 | -5.828M |
| June 30, 2024 | -19.37M |
| March 31, 2024 | -2.431M |
| December 31, 2023 | -28.12M |
| September 30, 2023 | -28.82M |
| June 30, 2023 | -26.78M |
| March 31, 2023 | -21.19M |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | -14.88M |
| March 31, 2022 | 96.10M |
| December 31, 2021 | -19.19M |
| September 30, 2021 | -32.06M |
| June 30, 2021 | -31.96M |
| March 31, 2021 | -27.48M |
| December 31, 2020 | -5.738M |
| September 30, 2020 | -191.52M |
| June 30, 2020 | -23.49M |
| March 31, 2020 | -9.452M |
| December 31, 2019 | -16.54M |
| September 30, 2019 | -5.529M |
| June 30, 2019 | -7.523M |
| March 31, 2019 | -6.678M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | -12.38M |
| BioNTech SE | -954.35M |
| Moderna, Inc. | -782.00M |
| Intellia Therapeutics, Inc. | -106.63M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 83.29M |
| EPS Diluted (Quarterly) | -0.5316 |
| Enterprise Value | 754.82M |
| Profit Margin (Quarterly) | -683.4% |
| Earnings Yield | -20.30% |
| Normalized Earnings Yield | -20.31 |